Understand your health. Know what to ask.

Bone density and body composition: which DXA scan are you booking?
A bone-density scan and a whole-body composition scan answer different questions. Check what is measured before comparing results.
Read · 2 min →
Postpartum fatigue: what ferritin and cortisol can tell you
Iron status can matter after childbirth, while cortisol tests answer specific endocrine questions. Persistent fatigue needs its full context.
6 sources · NIHRead · 2 min →
503A and 503B: how compounding oversight differs
What the two U.S. compounding frameworks mean for prescriptions, facility oversight and manufacturing requirements.
4 sources · FDARead · 2 min →
The first month of GLP-1 treatment: what early progress can look like
Early GLP-1 treatment involves tolerability and changing appetite. Long-term trial averages do not predict a first-month weight result.
2 sources · NIHRead · 2 min →
Before a longevity panel: what makes a test useful?
An expanded panel is useful when its results answer a clear question. Here is how to assess the purpose, interpretation and follow-up.
Read · 2 min →
What “not FDA-approved” means for compounded semaglutide
The distinction applies to the finished preparation. What FDA has reviewed, what it has not, and why the individual medical reason matters.
3 sources · FDARead · 2 min →
ApoB, Lp(a) and hs-CRP: three tests, different questions
ApoB reflects particle concentration, Lp(a) adds inherited risk information, and hs-CRP measures inflammation. How their roles differ.
Read · 2 min →
Sleep, alcohol and sexual function: what belongs in the review
Sleep patterns and alcohol use can matter when sexual symptoms persist. They are context for an evaluation, not proof of a single cause.
3 sources · NIHRead · 2 min →
Finasteride and brain fog: what is known
Brain fog has been reported with finasteride. Here is what FDA safety reports can tell you, what remains uncertain and why the formulation matters.
3 sources · FDARead · 2 min →
Your first blood draw when you work nights
Night work does not make blood tests unusable. A clear collection plan records sleep timing, fasting instructions, medicines and the purpose of each test.
Read · 2 min →
GLP-1 “microdosing” for maintenance: what is established?
Maintenance trials support continued treatment in specific regimens. They do not establish that any tiny dose or intermittent schedule will preserve results.
6 sources · FDA, NIH, PubMed / PMCRead · 2 min →
Visceral fat around menopause: why the scale can miss a change
Research finds changes in abdominal fat and lean mass during menopause. What those findings mean, and what a waist measurement cannot prove.
3 sources · PubMed / PMC, NIHRead · 2 min →